تاريخ الإيرادات والأرباح والتدفقات النقدية من القوائم المالية الرسمية.
Alexandria Real Estate Equities, Inc., is a mission-driven life science REIT. The firm is pioneered the life science real estate niche. The firm is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City. Alexandria Real Estate Equities, Inc. was established on 5th January 1994 and was incorporated in Maryland.
الرسوم البيانية التفاعلية والقوائم الكاملة ← نموذج التقييم (DCF) ←
| قائمة الدخل | TTM → 2026-09-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| إجمالي الإيرادات | $2.7B | $3.0B | $3.0B | $2.8B | $2.6B | $2.1B | $1.9B | $1.5B | $1.3B | $1.1B | $898M | $820M | $727M | $631M | $586M | $510M | $487M | $491M | ($79M) | $317M | $245M |
| إجمالي الربح | $1.8B | $2.0B | $2.1B | $2.0B | $1.8B | $1.5B | $1.4B | $1.1B | $946M | $799M | $619M | $558M | $508M | $442M | $412M | $341M | $355M | $371M | ($193M) | $218M | $245M |
| هامش الربح الإجمالي % | 67.3% | 68.9% | 70.2% | 69.8% | 69.6% | 70.5% | 71.9% | 70.9% | 71.3% | 71.0% | 69.0% | 68.1% | 69.8% | 70.0% | 70.2% | 66.9% | 72.9% | 75.5% | 245.4% | 68.7% | 100.0% |
| الدخل التشغيلي (EBIT) | ($1.3B) | ($1.2B) | $770M | $690M | $613M | $530M | $532M | $443M | $422M | $181M | $41M | $137M | $181M | $131M | $103M | $195M | $205M | $216M | $202M | $182M | $145M |
| هامش التشغيل % | -48.8% | -40.5% | 25.2% | 24.3% | 23.8% | 25.1% | 28.2% | 28.9% | 31.8% | 16.1% | 4.6% | 16.7% | 24.9% | 20.8% | 17.6% | 38.2% | 42.0% | 43.9% | -255.9% | 57.5% | 59.0% |
| صافي الدخل | ($1.4B) | ($1.4B) | $323M | $104M | $522M | $571M | $771M | $363M | $379M | $169M | ($66M) | $144M | $102M | $136M | $102M | $131M | $135M | $135M | $116M | $94M | $73M |
| هامش الربح الصافي % | -51.2% | -48.1% | 10.6% | 3.6% | 20.2% | 27.0% | 40.9% | 23.7% | 28.6% | 15.0% | -7.3% | 17.6% | 14.0% | 21.6% | 17.4% | 25.8% | 27.8% | 27.4% | -147.6% | 29.6% | 29.9% |
| EBITDA | — | $360M | $1.9B | $1.4B | $1.8B | $1.4B | $1.2B | $987M | $900M | $611M | $264M | $407M | $323M | $324M | $290M | $294M | $206M | $323M | $312M | $275M | $223M |
| ربحية السهم (EPS) | $-8.41 | $-8.40 | $1.88 | $0.61 | $3.23 | $3.87 | $6.10 | $3.23 | $3.67 | $1.84 | $-0.87 | $2.02 | $1.43 | $2.00 | $1.64 | $2.22 | $2.80 | $3.49 | $3.64 | $3.12 | $2.88 |
| الأسهم القائمة (م) | — | 170M | 172M | 171M | 162M | 147M | 126M | 113M | 103M | 92M | 76M | 72M | 71M | 68M | 62M | 59M | 48M | 39M | 32M | 30M | 25M |
المصدر: التقارير العامة للشركة (SEC). تحقق من SEC EDGAR قبل الاعتماد على أي رقم.
الميزانيات والتدفقات النقدية والبيانات الفصلية والنسب المالية الكاملة في العارض التفاعلي لـ ARE. /companies/us/ARE
المعلومات في هذا الموقع لأغراض تعليمية وإعلامية فقط ولا تشكل نصيحة استثمارية. لا تُنشر أسعار مستهدفة أو توصيات.
About TickerBase · Data methodology & sources · Privacy · Terms